Contact
Please use this form to send email to PR contact of this press release:
Cantabio Pharmaceuticals and Purdue Research Foundation Sign Cooperation Agreement to Investigate the Targeting of DJ-1 Protein for Treating Parkinson’s Disease and Other Neurodegenerative Diseases
TO: